Bunker Hill Announces Election to Issue Shares in Satisfaction of Debenture Interest Payment Obligations
20 sept. 2024 19h00 HE
|
Bunker Hill Mining Corp.
VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHILL) announces that it has elected to issue an...
Viridien selected to support technology-driven mineral exploration program in Oman
19 sept. 2024 01h30 HE
|
Viridien
Paris, France – September 19, 2024 Viridien has been awarded a comprehensive remote sensing program by Minerals Development Oman (MDO), the leading mining entity in the Sultanate of Oman, to...
Viridien sélectionné pour sa technologie de pointe en support d’un programme d’exploration minier en Oman
19 sept. 2024 01h30 HE
|
Viridien
Paris, France – Septembre 19, 2024 Viridien s’est vu attribuer un programme complet de télédétection par Minerals Development Oman (MDO), la principale entité minière du Sultanat d’Oman, afin...
COURTOIS SA : Rapports semestriels au 30 juin 2024
18 sept. 2024 11h30 HE
|
COURTOIS
COURTOIS SA : Rapports semestriels au 30 juin 2024
Pièce jointe
CSArapports30062024
...
BridgeBio Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation by the FDA
17 sept. 2024 07h30 HE
|
BridgeBio Pharma, Inc.
- Breakthrough Therapy Designation was granted based on preliminary clinical evidence from the PROPEL 2 clinical trial, meeting the FDA’s requirement of potentially demonstrating substantial...
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 sept. 2024 07h00 HE
|
EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...
Virbac : Half-yearly financial report 2024
13 sept. 2024 12h15 HE
|
Virbac
Please find attached 2024 Half-yearly financial report of Virbac
Attachment
Half-Yearly Financial Report_2024 for publication
...
Virbac : Rapport financier semestriel 2024
13 sept. 2024 12h15 HE
|
Virbac
Ci-joint le rapport financier semestriel 2024 de Virbac
Pièce jointe
Rapport financier semestriel_2024 pour publication
...
Fancamp Files Technical Report on New Brunswick Riley Brook Project in Prospective Copper-Gold Region
13 sept. 2024 07h45 HE
|
Fancamp Exploration Ltd.
VANCOUVER, British Columbia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that it has filed an...
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
12 sept. 2024 22h34 HE
|
Centessa Pharmaceuticals plc
BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are...